2m 2m 2m 2m 2m 2m 2m
AARDVARK THERA (AARD)
NASDAQ
$4.97+$0.56 (+12.65%)
Price as of Oct 22, 2026 8:00 PM EDT- $96.5MMarket Cap
- -59.80%1-Year Change
- BiotechnologyIndustry
AARDVARK THERA (AARD)
$4.97+$0.56 (+12.65%)
AARD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.41 | ||
Change | +$0.51 (+13.08%) | ||
Open | $3.95 | ||
High | $4.54 | ||
Low | $3.95 | ||
Previous Close | $3.90 | ||
Volume | 218,456 | ||
30-Day Average Volume | 120,535 | ||
1-Week Change | 13.66% | ||
1-Month Change | -20.83% | ||
1-Year Change | -59.80% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 21.9M | ||
Total Assets | $81.5M | ||
Market Cap | $96.5M | ||
Enterprise Value | $22.7M | ||
Period: QTR TTM FY | |||
Revenue | $2,000.00 | ||
Net Income | -$14.4M | ||
Free Cash Flow | -$17.6M | ||
EBIT | -$14.4M | ||
EBITDA | -$14.4M | ||
Net Working Capital | $74.3M | ||
EPS | -$0.66 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | 11,332 | ||
P/B | 1 | ||
P/E | -7 | ||
PEG | -0 | ||
Price/Free Cash Flow | -5 | ||
Price/Operating Cash Flow | -5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 2 | ||
Last Split Date | 07/21/2008 | ||
Earnings & Revenue